Approvals (Drugs@FDA)

JUVMO, JUVMO (COPACKAGED)

ABBVIE · TAVAPADON

NDA220415Drug (NDA)Prescription
Open FDA's page for this record
Application number
NDA220415
Sponsor name
ABBVIE
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260925
    Review priority
    STANDARD
    Submission class code
    TYPE 1
    Submission class code description
    Type 1 - New Molecular Entity
    Application docs
    1. ID
      87314
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220415Orig1s000ltr.pdf
      Date
      20260929
      Type
      Letter
    2. ID
      87353
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220415Orig1s000lbl.pdf
      Date
      20261006
      Type
      Label
Products
  1. Product number
    004
    Reference drug
    Yes
    Brand name
    JUVMO
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      TAVAPADON
      Strength
      15MG
  2. Product number
    002
    Reference drug
    Yes
    Brand name
    JUVMO
    Reference standard
    Yes
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      TAVAPADON
      Strength
      5MG
  3. Product number
    005
    Reference drug
    No
    Brand name
    JUVMO
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      TAVAPADON
      Strength
      15MG
  4. Product number
    003
    Reference drug
    Yes
    Brand name
    JUVMO
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      TAVAPADON
      Strength
      10MG
  5. Product number
    001
    Reference drug
    Yes
    Brand name
    JUVMO (COPACKAGED)
    Reference standard
    Yes
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      TAVAPADON
      Strength
      0.25MG
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.